DNA配列の世界市場:インサイト、市場機会、市場シェア、市場予測

◆英語タイトル:Global DNA Sequencing Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022
◆商品コード:OCCAM60906
◆発行会社(調査会社):Occams Research
◆発行日:2016年7月
◆ページ数:140
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single UserUSD3,900 ⇒換算¥444,600見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD5,900 ⇒換算¥672,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はOccams Research社の日本における正規販売代理店です。Occams Research社の概要及び新刊レポートはこちらでご確認いただけます。
本調査レポートでは、DNA配列の世界市場について調査・分析し、市場インサイト、市場機会、市場シェア、市場規模予測などを含め、以下の構成でお届けいたします。

・DNA配列の世界市場:イントロダクション
・DNA配列の世界市場:市場概観
・DNA配列の世界市場:市場動向(促進要因、阻害要因、市場機会)
・DNA配列の世界市場:セグメント別市場分析
・DNA配列の世界市場:需要先別分析/市場規模
・DNA配列の世界市場:技術別分析/市場規模
・DNA配列の世界市場:用途別分析/市場規模
・DNA配列の世界市場:主要地域別市場分析
・DNA配列の世界市場:関連企業分析
【レポートの概要】

The global DNA sequencing market is expected to grow with an impressive double digit CAGR of 19.30% during 2016-2022. The major factor which is contributing towards the growth of the market is the rising research and development spending by biotechnology companies. The major key players are investing huge amount of money on the research and development activities. Region wise, Europe’s research spending was the high in 2013, with UK spending $1.2 billion on R&D; France spending $695 million; and, Germany putting up $147 million in the same year. Also, the increasing demand for personalized medicine is anticipated to fuel the growth of global market.
The several developed countries have taken various initiatives for the development of personalized medicines. In 2015, the United States President Barack Obama has announced that the government is going to invest $215 million for the development of personalized medicines. The personalized medicines are used to cure a number of diseases, but the major share is accounted by oncology with 38%; psychiatry 17%; infectious diseases 10%; 7% share of cardiology; endocrinology and neurology accounting for 6% each; gastroenterology 5% and others accounts for a combined 11%. The increasing use of personalized medicines is increasing the scope of DNA sequencing technology in the global market. By the use of personalized medicines, the 5-year survival rate is increased to 70%. Personalized medicines help to reduce the cost of healthcare that is the primary reason for its increasing demand, worldwide. In 2015, it is estimated that around $604 million healthcare cost is saved by the use of personalized medicines.

Although, there are many factors that are driving growth in the market, however, there are some challenges such as dearth of effective bioinformatics tools which helps the researcher to innovate new technology is the major challenge that can be surpassed during the forecast period. The absence of skilled professionals and requirement of high capital investment are the major restraints which are hindering the growth of global DNA sequencing technology market.

Global gene sequencing market is segmented on the basis of application, technology, and end user. On the basis of technology, the market is further divided into: Sequencing by Synthesis (SBS); ION Semiconductor Sequencing; Sequencing by Ligation (SBL); and, Pyrosequencing. On the basis of application, the market is further divided in Diagnostics; Drug Discovery; Biomarker Discovery; Modified Medicine; Agriculture & Animal Research; and, others. End user segment is further categorized into Research Centers and Academic & Government Institutes; Hospitals & Clinics; Pharmaceutical & Biotechnology Companies; and some others like NPO, Agri genomics Organizations, Consumer Genomic Companies, etc. Geographically, the market is segmented by four major regions of North America, Europe, Asia Pacific, and rest of the world. North America region dominates the global market, followed by Europe, APAC and ROW. The North America holds the largest share of the global market.

The sequencing industry is witnessing intense competition from numerous top market players; such as Illumina, Inc.; Roche; and, Thermo Fisher, etc., operating in the market along with small promising players like Pacific Biosciences. The presence of competition prevailing in the sequencing industry has been estimated by a number of parameters such as developing market exposure, R&D expenditures, and presence in different market segments.

【レポートの目次】

1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW
2.1. MARKET DEFINITION AND SCOPE
2.2. NOVEL TECHNOLOGY: DNA SEQUENCING
2.3. KEY FINDINGS
2.4. PARAMETRIC ANALYSIS
2.5. KEY MARKET INSIGHTS
2.5.1. TOP EMERGING COUNTRIES
2.5.2. TOP REVENUE GENERATING SEGMENTS
2.5.3. TOP GROWING MARKETS AND EMERGING TRENDS
2.5.4. TOP GEOGRAPHY
2.6. COMPETITIVE LANDSCAPE
2.6.1. MARKET SHARE ANALYSIS
2.6.2. TOP WINNING STRATEGIES
2.6.3. CASE STUDIES: TOP COMPETITIVE MOVES
2.7. PORTER’S FIVE FORCE MODEL
2.7.1. THREAT OF NEW ENTRANTS
2.7.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
2.7.3. BARGAINING POWER OF BUYER
2.7.4. BARGAINING POWER OF SUPPLIER
2.7.5. INTENSITY OF COMPETITIVE RIVALRY
2.8. KEY BUYING CRITERIA
2.9. STRATEGIC RECOMMENDATION
2.10. STRATEGIC CONCLUSIONS

3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. GROWING BREEDERS REQUIREMENTS
3.1.2. EMERGING AND APPLIED MARKETS
3.1.3. EXPOSURE TO RESEARCH AND DEVELOPMENT
3.1.4. INCREASING PREVALENCE OF CANCER
3.1.5. ENTRY OF NEW MARKET PLAYERS
3.1.6. CONFERENCES AND WORKSHOPS INCREASING AWARENESS ON PRODUCTS AND SERVICES
3.2. MARKET RESTRAINTS
3.2.1. HIGH COST INVOLVED
3.2.2. ACCURACY & STANDARDIZATION CONCERNS IN DIAGNOSTIC TESTING
3.2.3. LACK OF SKILLED PROFESSIONALS
3.3. MARKET OPPORTUNITIES
3.3.1. DEVELOPING COUNTRIES LIKE APAC AND LATIN AMERICA SHOW HUGE GROWTH
3.3.2. PERSONALIZED MEDICINE & BIOMARKER DISCOVERY OPEN AVENUES FOR THE GROWTH OF NEXT GENERATION SEQUENCING MARKET
3.4. MARKET CHALLENGES
3.4.1. FRONT AND BACK-END CHALLENGES
3.4.2. INFORMATICS LIMITATION
3.5. PARENT MARKET
3.6. COMPETITORS MARKET
3.7. ALTERNATIVE MARKET

4. MARKET SEGMENTATION
4.1. BY END USER
4.1.1. GLOBAL DNA SEQUENCING MARKET BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 2014-2022 ($ MILLION)
4.1.2. GLOBAL DNA SEQUENCING MARKET BY HOSPITALS & CLINICS 2014-2022 ($ MILLION)
4.1.3. GLOBAL DNA SEQUENCING MARKET BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 2014-2022 ($ MILLION)
4.1.4. GLOBAL DNA SEQUENCING MARKET BY OTHER END-USERS (NPO, AGRI GENOMICS ORGANIZATIONS, CONSUMER GENOMIC COMPANIES) 2014-2022 ($ MILLION)
4.2. BY TECHNOLOGY
4.2.1. GLOBAL DNA SEQUENCING MARKET BY SEQUENCING BY SYNTHESIS (SBS) 2014-2022 ($ MILLION)
4.2.2. GLOBAL DNA SEQUENCING MARKET BY ION SEMICONDUCTOR SEQUENCING 2014-2022 ($ MILLION)
4.2.3. GLOBAL DNA SEQUENCING MARKET BY SEQUENCING BY LIGATION (SBL) 2014-2022 ($ MILLION)
4.2.4. GLOBAL DNA SEQUENCING MARKET BY PYROSEQUENCING 2014-2022 ($ MILLION)
4.2.5. GLOBAL DNA SEQUENCING MARKET BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) 2014-2022 ($ MILLION)
4.2.6. GLOBAL DNA SEQUENCING MARKET BY OTHER TECHNOLOGIES 2014-2022 ($ MILLION)
4.3. BY APPLICATION
4.3.1. GLOBAL DNA SEQUENCING MARKET BY DIAGNOSTICS 2014-2022 ($ MILLION)
4.3.2. GLOBAL DNA SEQUENCING MARKET BY DRUG DISCOVERY 2014-2022 ($ MILLION)
4.3.3. GLOBAL DNA SEQUENCING MARKET BY BIOMARKER DISCOVERY 2014-2022 ($ MILLION)
4.3.4. GLOBAL DNA SEQUENCING MARKET BY PERSONALIZED MEDICINE 2014-2022 ($ MILLION)
4.3.5. GLOBAL DNA SEQUENCING MARKET BY AGRICULTURE & ANIMAL RESEARCH 2014-2022 ($ MILLION)
4.3.6. GLOBAL DNA SEQUENCING MARKET BY OTHER APPLICATIONS 2014-2022 ($ MILLION)

5. GEOGRAPHICAL ANALYSIS
5.1. NORTH AMERICA GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
5.1.1. UNITED STATES (U.S.) GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
5.1.2. CANADA GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
5.2. EUROPE GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
5.2.1. UNITED KINGDOM (UK) GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
5.2.2. FRANCE GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
5.2.3. GERMANY GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
5.2.4. SPAIN GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
5.2.5. ITALY GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
5.2.6. ROE GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
5.3. ASIA PACIFIC GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
5.3.1. INDIA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
5.3.2. CHINA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
5.3.3. JAPAN REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
5.3.4. KOREA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
5.3.5. AUSTRALIA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
5.3.6. ROAPAC REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
5.4. REST OF THE WORLD GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
5.4.1. LATIN AMERICA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
5.4.2. MENA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
5.4.3. AFRICA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)

6. COMPANY PROFILES
1. 23ANDME, INC.
2. ADAPTIVE BIOTECHNOLOGIES, INC.
3. AGILENT TECHNOLOGIES, INC.
4. APPISTRY, INC.
5. ASURAGEN, INC.
6. ATHENA DIAGNOSTICS, INC.
7. CELL MICROSYSTEMS,, INC.
8. CELLULAR RESEARCH, INC.
9. SPIRAL GENETICS, INC.
10. SUNDANCE DIAGNOSTICS, INC.
11. SURE GENOMICS, INC.
12. THERMO FISHER SCIENTIFIC, INC.
13. THORNE DIAGNOSTICS, INC.
14. UBIQUITY GENOMICS, INC.
15. WAFERGEN BIO-SYSTEMS, INC.

LIST OF TABLES
1. GLOBAL DNA SEQUENCING MARKET BY END USER 2014-2022 ($ MILLION)
2. GLOBAL DNA SEQUENCING MARKET BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 2014-2022 ($ MILLION)
3. GLOBAL DNA SEQUENCING MARKET BY HOSPITALS & CLINICS 2014-2022 ($ MILLION)
4. GLOBAL DNA SEQUENCING MARKET BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 2014-2022 ($ MILLION)
5. GLOBAL DNA SEQUENCING MARKET BY OTHER END-USERS (NPO, AGRI GENOMICS ORGANIZATIONS, CONSUMER GENOMIC COMPANIES) 2014-2022 ($ MILLION)
6. GLOBAL DNA SEQUENCING MARKET BY TECHNOLOGY 2014-2022 ($ MILLION)
7. GLOBAL DNA SEQUENCING MARKET BY SEQUENCING BY SYNTHESIS (SBS) 2014-2022 ($ MILLION)
8. GLOBAL DNA SEQUENCING MARKET BY ION SEMICONDUCTOR SEQUENCING 2014-2022 ($ MILLION)
9. GLOBAL DNA SEQUENCING MARKET BY SEQUENCING BY LIGATION (SBL) 2014-2022 ($ MILLION)
10. GLOBAL DNA SEQUENCING MARKET BY PYROSEQUENCING 2014-2022 ($ MILLION)
11. GLOBAL DNA SEQUENCING MARKET BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) 2014-2022 ($ MILLION)
12. GLOBAL DNA SEQUENCING MARKET BY OTHER TECHNOLOGIES 2014-2022 ($ MILLION)
13. GLOBAL DNA SEQUENCING MARKET BY APPLICATION 2014-2022 ($ MILLION)
14. GLOBAL DNA SEQUENCING MARKET BY DIAGNOSTICS 2014-2022 ($ MILLION)
15. GLOBAL DNA SEQUENCING MARKET BY DRUG DISCOVERY 2014-2022 ($ MILLION)
16. GLOBAL DNA SEQUENCING MARKET BY BIOMARKER DISCOVERY 2014-2022 ($ MILLION)
17. GLOBAL DNA SEQUENCING MARKET BY PERSONALIZED MEDICINE 2014-2022 ($ MILLION)
18. GLOBAL DNA SEQUENCING MARKET BY AGRICULTURE & ANIMAL RESEARCH 2014-2022 ($ MILLION)
19. GLOBAL DNA SEQUENCING MARKET BY OTHER APPLICATIONS 2014-2022 ($ MILLION)
20. NORTH AMERICA GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
21. EUROPE GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
22. ASIA PACIFIC GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
23. REST OF THE WORLD GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)

LIST OF FIGURES

1. GLOBAL DNA SEQUENCING MARKET BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 2014-2022 ($ MILLION)
2. GLOBAL DNA SEQUENCING MARKET BY HOSPITALS & CLINICS 2014-2022 ($ MILLION)
3. GLOBAL DNA SEQUENCING MARKET BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 2014-2022 ($ MILLION)
4. GLOBAL DNA SEQUENCING MARKET BY OTHER END-USER (NPO, AGRI GENOMICS ORGANIZATIONS, CONSUMER GENOMIC COMPANIES) 2014-2022 ($ MILLION)
5. GLOBAL DNA SEQUENCING MARKET BY SEQUENCING BY SYNTHESIS (SBS) 2014-2022 ($ MILLION)
6. GLOBAL DNA SEQUENCING MARKET BY ION SEMICONDUCTOR SEQUENCING 2014-2022 ($ MILLION)
7. GLOBAL DNA SEQUENCING MARKET BY SEQUENCING BY LIGATION (SBL) 2014-2022 ($ MILLION)
8. GLOBAL DNA SEQUENCING MARKET BY PYROSEQUENCING 2014-2022 ($ MILLION)
9. GLOBAL DNA SEQUENCING MARKET BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) 2014-2022 ($ MILLION)
10. GLOBAL DNA SEQUENCING MARKET BY OTHER TECHNOLOGIES 2014-2022 ($ MILLION)
11. GLOBAL DNA SEQUENCING MARKET BY DIAGNOSTICS 2014-2022 ($ MILLION)
12. GLOBAL DNA SEQUENCING MARKET BY DRUG DISCOVERY 2014-2022 ($ MILLION)
13. GLOBAL DNA SEQUENCING MARKET BY BIOMARKER DISCOVERY 2014-2022 ($ MILLION)
14. GLOBAL DNA SEQUENCING MARKET BY PERSONALIZED MEDICINE 2014-2022 ($ MILLION)
15. GLOBAL DNA SEQUENCING MARKET BY AGRICULTURE & ANIMAL RESEARCH 2014-2022 ($ MILLION)
16. GLOBAL DNA SEQUENCING MARKET BY OTHER APPLICATIONS 2014-2022 ($ MILLION)
17. NORTH AMERICA GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
18. UNITED STATES (U.S.) GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
19. CANADA GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
20. EUROPE GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
21. UNITED KINGDOM (UK) GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
22. FRANCE GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
23. GERMANY GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
24. SPAIN GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
25. ITALY GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
26. ROE GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
27. ASIA PACIFIC GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
28. INDIA GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
29. CHINA GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
30. JAPAN GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
31. KOREA GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
32. AUSTRALIA GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
33. ROAPAC GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
34. REST OF THE WORLD GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
35. LATIN AMERICA GLOBAL RESPIRATORY MONITOR DEVICE MARKET 2014-2022 ($ MILLION)
36. MENA GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)
37. AFRICA GLOBAL DNA SEQUENCING MARKET 2014-2022 ($ MILLION)



【レポートのキーワード】

塩基合成、SBS法、イオン半導体シーケンシング、パイロシーケンシング

★調査レポート[DNA配列の世界市場:インサイト、市場機会、市場シェア、市場予測]販売に関する免責事項
★調査レポート[DNA配列の世界市場:インサイト、市場機会、市場シェア、市場予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆